Location History:
- Royston, GB (2012 - 2014)
- Hertfordshire, GB (2015)
Company Filing History:
Years Active: 2012-2015
Title: The Innovations of Inventor Steven Hawker
Introduction: Steven Hawker, an accomplished inventor based in Hertfordshire, GB, has made significant contributions to the field of pharmaceuticals with a total of four patented inventions. His work focuses on innovative processes related to chemical compounds, particularly in the development of NEP-inhibitors.
Latest Patents: Among his latest patents is a groundbreaking process for preparing 5-biphenyl-4-amino-2-methyl pentanoic acid. This invention relates to pyrrolidin-2-ones, which are crucial in the development of new therapeutic agents. The patent describes methods for their preparation and applications in the creation of N-(3-carboxyl-1-oxopropyl)-(4S)-(p-phenylphenylmethyl)-4-amino-(2R)-methyl butanoic acid ethyl ester or its salts. This innovative process aims to enhance the efficiency of NEP-inhibitors, which are vital in various medical treatments.
Career Highlights: Steven Hawker is currently affiliated with Novartis AG, a prominent global healthcare company. His tenure at Novartis AG has allowed him to engage in cutting-edge research and development, contributing valuable intellectual property to the organization.
Collaborations: Throughout his career, Steven has collaborated with notable colleagues, including David Hook and Thomas Ruch. These collaborations have fostered an environment of innovation, leading to the successful development of multiple patents and advancements in pharmaceutical sciences.
Conclusion: Steven Hawker exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the realm of NEP-inhibitors, demonstrate the critical role inventors play in advancing medical science. With his continued dedication to research and development, the future looks promising for further breakthroughs that can benefit healthcare systems worldwide.